Click for best price
Drugs for Pain Management Market Size, Share 2022
Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques.
This report contains market size and forecasts of Drugs for Pain Management in Global, including the following market information:
Global Drugs for Pain Management Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Drugs for Pain Management market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Generic Opioid Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Drugs for Pain Management include GSK, Pfizer, Grunenthal, Sanofi, Bayer, AstraZeneca, Eli Lilly, Endo and Merck, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Drugs for Pain Management companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drugs for Pain Management Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Drugs for Pain Management Market Segment Percentages, by Type, 2021 (%)
Generic Opioid
Branded Opioids
NSAIDs
Others
Global Drugs for Pain Management Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Drugs for Pain Management Market Segment Percentages, by Application, 2021 (%)
Hospitals
Drugstores
Others
Global Drugs for Pain Management Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Drugs for Pain Management Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Drugs for Pain Management revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Drugs for Pain Management revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GSK
Pfizer
Grunenthal
Sanofi
Bayer
AstraZeneca
Eli Lilly
Endo
Merck
Yunnan Baiyao
Teikoku Seiyaku
Teva
J&J
Assertio Therapeutics
Allergan
| Report Attributes |
Report Details |
| Report Title |
Drugs for Pain Management Market - Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
102 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Drugs for Pain Management Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Drugs for Pain Management Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Drugs for Pain Management Overall Market Size
2.1 Global Drugs for Pain Management Market Size: 2021 VS 2028
2.2 Global Drugs for Pain Management Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Drugs for Pain Management Players in Global Market
3.2 Top Global Drugs for Pain Management Companies Ranked by Revenue
3.3 Global Drugs for Pain Management Revenue by Companies
3.4 Top 3 and Top 5 Drugs for Pain Management Companies in Global Market, by Revenue in 2021
3.5 Global Companies Drugs for Pain Management Product Type
3.6 Tier 1, Tier 2 and Tier 3 Drugs for Pain Management Players in Global Market
3.6.1 List of Global Tier 1 Drugs for Pain Management Companies
3.6.2 List of Global Tier 2 and Tier 3 Drugs for Pain Management Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Drugs for Pain Management Market Size Markets, 2021 & 2028
4.1.2 Generic Opioid
4.1.3 Branded Opioids
4.1.4 NSAIDs
4.1.5 Others
4.2 By Type - Global Drugs for Pain Management Revenue & Forecasts
4.2.1 By Type - Global Drugs for Pain Management Revenue, 2017-2022
4.2.2 By Type - Global Drugs for Pain Management Revenue, 2023-2028
4.2.3 By Type - Global Drugs for Pain Management Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Drugs for Pain Management Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Drugstores
5.1.4 Others
5.2 By Application - Global Drugs for Pain Management Revenue & Forecasts
5.2.1 By Application - Global Drugs for Pain Management Revenue, 2017-2022
5.2.2 By Application - Global Drugs for Pain Management Revenue, 2023-2028
5.2.3 By Application - Global Drugs for Pain Management Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Drugs for Pain Management Market Size, 2021 & 2028
6.2 By Region - Global Drugs for Pain Management Revenue & Forecasts
6.2.1 By Region - Global Drugs for Pain Management Revenue, 2017-2022
6.2.2 By Region - Global Drugs for Pain Management Revenue, 2023-2028
6.2.3 By Region - Global Drugs for Pain Management Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Drugs for Pain Management Revenue, 2017-2028
6.3.2 US Drugs for Pain Management Market Size, 2017-2028
6.3.3 Canada Drugs for Pain Management Market Size, 2017-2028
6.3.4 Mexico Drugs for Pain Management Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Drugs for Pain Management Revenue, 2017-2028
6.4.2 Germany Drugs for Pain Management Market Size, 2017-2028
6.4.3 France Drugs for Pain Management Market Size, 2017-2028
6.4.4 U.K. Drugs for Pain Management Market Size, 2017-2028
6.4.5 Italy Drugs for Pain Management Market Size, 2017-2028
6.4.6 Russia Drugs for Pain Management Market Size, 2017-2028
6.4.7 Nordic Countries Drugs for Pain Management Market Size, 2017-2028
6.4.8 Benelux Drugs for Pain Management Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Drugs for Pain Management Revenue, 2017-2028
6.5.2 China Drugs for Pain Management Market Size, 2017-2028
6.5.3 Japan Drugs for Pain Management Market Size, 2017-2028
6.5.4 South Korea Drugs for Pain Management Market Size, 2017-2028
6.5.5 Southeast Asia Drugs for Pain Management Market Size, 2017-2028
6.5.6 India Drugs for Pain Management Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Drugs for Pain Management Revenue, 2017-2028
6.6.2 Brazil Drugs for Pain Management Market Size, 2017-2028
6.6.3 Argentina Drugs for Pain Management Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Drugs for Pain Management Revenue, 2017-2028
6.7.2 Turkey Drugs for Pain Management Market Size, 2017-2028
6.7.3 Israel Drugs for Pain Management Market Size, 2017-2028
6.7.4 Saudi Arabia Drugs for Pain Management Market Size, 2017-2028
6.7.5 UAE Drugs for Pain Management Market Size, 2017-2028
7 Players Profiles
7.1 GSK
7.1.1 GSK Corporate Summary
7.1.2 GSK Business Overview
7.1.3 GSK Drugs for Pain Management Major Product Offerings
7.1.4 GSK Drugs for Pain Management Revenue in Global Market (2017-2022)
7.1.5 GSK Key News
7.2 Pfizer
7.2.1 Pfizer Corporate Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Drugs for Pain Management Major Product Offerings
7.2.4 Pfizer Drugs for Pain Management Revenue in Global Market (2017-2022)
7.2.5 Pfizer Key News
7.3 Grunenthal
7.3.1 Grunenthal Corporate Summary
7.3.2 Grunenthal Business Overview
7.3.3 Grunenthal Drugs for Pain Management Major Product Offerings
7.3.4 Grunenthal Drugs for Pain Management Revenue in Global Market (2017-2022)
7.3.5 Grunenthal Key News
7.4 Sanofi
7.4.1 Sanofi Corporate Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Drugs for Pain Management Major Product Offerings
7.4.4 Sanofi Drugs for Pain Management Revenue in Global Market (2017-2022)
7.4.5 Sanofi Key News
7.5 Bayer
7.5.1 Bayer Corporate Summary
7.5.2 Bayer Business Overview
7.5.3 Bayer Drugs for Pain Management Major Product Offerings
7.5.4 Bayer Drugs for Pain Management Revenue in Global Market (2017-2022)
7.5.5 Bayer Key News
7.6 AstraZeneca
7.6.1 AstraZeneca Corporate Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Drugs for Pain Management Major Product Offerings
7.6.4 AstraZeneca Drugs for Pain Management Revenue in Global Market (2017-2022)
7.6.5 AstraZeneca Key News
7.7 Eli Lilly
7.7.1 Eli Lilly Corporate Summary
7.7.2 Eli Lilly Business Overview
7.7.3 Eli Lilly Drugs for Pain Management Major Product Offerings
7.7.4 Eli Lilly Drugs for Pain Management Revenue in Global Market (2017-2022)
7.7.5 Eli Lilly Key News
7.8 Endo
7.8.1 Endo Corporate Summary
7.8.2 Endo Business Overview
7.8.3 Endo Drugs for Pain Management Major Product Offerings
7.8.4 Endo Drugs for Pain Management Revenue in Global Market (2017-2022)
7.8.5 Endo Key News
7.9 Merck
7.9.1 Merck Corporate Summary
7.9.2 Merck Business Overview
7.9.3 Merck Drugs for Pain Management Major Product Offerings
7.9.4 Merck Drugs for Pain Management Revenue in Global Market (2017-2022)
7.9.5 Merck Key News
7.10 Yunnan Baiyao
7.10.1 Yunnan Baiyao Corporate Summary
7.10.2 Yunnan Baiyao Business Overview
7.10.3 Yunnan Baiyao Drugs for Pain Management Major Product Offerings
7.10.4 Yunnan Baiyao Drugs for Pain Management Revenue in Global Market (2017-2022)
7.10.5 Yunnan Baiyao Key News
7.11 Teikoku Seiyaku
7.11.1 Teikoku Seiyaku Corporate Summary
7.11.2 Teikoku Seiyaku Business Overview
7.11.3 Teikoku Seiyaku Drugs for Pain Management Major Product Offerings
7.11.4 Teikoku Seiyaku Drugs for Pain Management Revenue in Global Market (2017-2022)
7.11.5 Teikoku Seiyaku Key News
7.12 Teva
7.12.1 Teva Corporate Summary
7.12.2 Teva Business Overview
7.12.3 Teva Drugs for Pain Management Major Product Offerings
7.12.4 Teva Drugs for Pain Management Revenue in Global Market (2017-2022)
7.12.5 Teva Key News
7.13 J&J
7.13.1 J&J Corporate Summary
7.13.2 J&J Business Overview
7.13.3 J&J Drugs for Pain Management Major Product Offerings
7.13.4 J&J Drugs for Pain Management Revenue in Global Market (2017-2022)
7.13.5 J&J Key News
7.14 Assertio Therapeutics
7.14.1 Assertio Therapeutics Corporate Summary
7.14.2 Assertio Therapeutics Business Overview
7.14.3 Assertio Therapeutics Drugs for Pain Management Major Product Offerings
7.14.4 Assertio Therapeutics Drugs for Pain Management Revenue in Global Market (2017-2022)
7.14.5 Assertio Therapeutics Key News
7.15 Allergan
7.15.1 Allergan Corporate Summary
7.15.2 Allergan Business Overview
7.15.3 Allergan Drugs for Pain Management Major Product Offerings
7.15.4 Allergan Drugs for Pain Management Revenue in Global Market (2017-2022)
7.15.5 Allergan Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Drugs for Pain Management Market Opportunities & Trends in Global Market
Table 2. Drugs for Pain Management Market Drivers in Global Market
Table 3. Drugs for Pain Management Market Restraints in Global Market
Table 4. Key Players of Drugs for Pain Management in Global Market
Table 5. Top Drugs for Pain Management Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Drugs for Pain Management Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Drugs for Pain Management Revenue Share by Companies, 2017-2022
Table 8. Global Companies Drugs for Pain Management Product Type
Table 9. List of Global Tier 1 Drugs for Pain Management Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Drugs for Pain Management Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Drugs for Pain Management Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Drugs for Pain Management Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Drugs for Pain Management Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Drugs for Pain Management Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Drugs for Pain Management Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Drugs for Pain Management Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Drugs for Pain Management Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Drugs for Pain Management Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Drugs for Pain Management Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Drugs for Pain Management Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Drugs for Pain Management Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Drugs for Pain Management Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Drugs for Pain Management Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Drugs for Pain Management Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Drugs for Pain Management Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Drugs for Pain Management Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Drugs for Pain Management Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Drugs for Pain Management Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Drugs for Pain Management Revenue, (US$, Mn), 2023-2028
Table 30. GSK Corporate Summary
Table 31. GSK Drugs for Pain Management Product Offerings
Table 32. GSK Drugs for Pain Management Revenue (US$, Mn), (2017-2022)
Table 33. Pfizer Corporate Summary
Table 34. Pfizer Drugs for Pain Management Product Offerings
Table 35. Pfizer Drugs for Pain Management Revenue (US$, Mn), (2017-2022)
Table 36. Grunenthal Corporate Summary
Table 37. Grunenthal Drugs for Pain Management Product Offerings
Table 38. Grunenthal Drugs for Pain Management Revenue (US$, Mn), (2017-2022)
Table 39. Sanofi Corporate Summary
Table 40. Sanofi Drugs for Pain Management Product Offerings
Table 41. Sanofi Drugs for Pain Management Revenue (US$, Mn), (2017-2022)
Table 42. Bayer Corporate Summary
Table 43. Bayer Drugs for Pain Management Product Offerings
Table 44. Bayer Drugs for Pain Management Revenue (US$, Mn), (2017-2022)
Table 45. AstraZeneca Corporate Summary
Table 46. AstraZeneca Drugs for Pain Management Product Offerings
Table 47. AstraZeneca Drugs for Pain Management Revenue (US$, Mn), (2017-2022)
Table 48. Eli Lilly Corporate Summary
Table 49. Eli Lilly Drugs for Pain Management Product Offerings
Table 50. Eli Lilly Drugs for Pain Management Revenue (US$, Mn), (2017-2022)
Table 51. Endo Corporate Summary
Table 52. Endo Drugs for Pain Management Product Offerings
Table 53. Endo Drugs for Pain Management Revenue (US$, Mn), (2017-2022)
Table 54. Merck Corporate Summary
Table 55. Merck Drugs for Pain Management Product Offerings
Table 56. Merck Drugs for Pain Management Revenue (US$, Mn), (2017-2022)
Table 57. Yunnan Baiyao Corporate Summary
Table 58. Yunnan Baiyao Drugs for Pain Management Product Offerings
Table 59. Yunnan Baiyao Drugs for Pain Management Revenue (US$, Mn), (2017-2022)
Table 60. Teikoku Seiyaku Corporate Summary
Table 61. Teikoku Seiyaku Drugs for Pain Management Product Offerings
Table 62. Teikoku Seiyaku Drugs for Pain Management Revenue (US$, Mn), (2017-2022)
Table 63. Teva Corporate Summary
Table 64. Teva Drugs for Pain Management Product Offerings
Table 65. Teva Drugs for Pain Management Revenue (US$, Mn), (2017-2022)
Table 66. J&J Corporate Summary
Table 67. J&J Drugs for Pain Management Product Offerings
Table 68. J&J Drugs for Pain Management Revenue (US$, Mn), (2017-2022)
Table 69. Assertio Therapeutics Corporate Summary
Table 70. Assertio Therapeutics Drugs for Pain Management Product Offerings
Table 71. Assertio Therapeutics Drugs for Pain Management Revenue (US$, Mn), (2017-2022)
Table 72. Allergan Corporate Summary
Table 73. Allergan Drugs for Pain Management Product Offerings
Table 74. Allergan Drugs for Pain Management Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Drugs for Pain Management Segment by Type in 2021
Figure 2. Drugs for Pain Management Segment by Application in 2021
Figure 3. Global Drugs for Pain Management Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Drugs for Pain Management Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Drugs for Pain Management Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Drugs for Pain Management Revenue in 2021
Figure 8. By Type - Global Drugs for Pain Management Revenue Market Share, 2017-2028
Figure 9. By Application - Global Drugs for Pain Management Revenue Market Share, 2017-2028
Figure 10. By Region - Global Drugs for Pain Management Revenue Market Share, 2017-2028
Figure 11. By Country - North America Drugs for Pain Management Revenue Market Share, 2017-2028
Figure 12. US Drugs for Pain Management Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Drugs for Pain Management Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Drugs for Pain Management Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Drugs for Pain Management Revenue Market Share, 2017-2028
Figure 16. Germany Drugs for Pain Management Revenue, (US$, Mn), 2017-2028
Figure 17. France Drugs for Pain Management Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Drugs for Pain Management Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Drugs for Pain Management Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Drugs for Pain Management Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Drugs for Pain Management Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Drugs for Pain Management Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Drugs for Pain Management Revenue Market Share, 2017-2028
Figure 24. China Drugs for Pain Management Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Drugs for Pain Management Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Drugs for Pain Management Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Drugs for Pain Management Revenue, (US$, Mn), 2017-2028
Figure 28. India Drugs for Pain Management Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Drugs for Pain Management Revenue Market Share, 2017-2028
Figure 30. Brazil Drugs for Pain Management Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Drugs for Pain Management Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Drugs for Pain Management Revenue Market Share, 2017-2028
Figure 33. Turkey Drugs for Pain Management Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Drugs for Pain Management Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Drugs for Pain Management Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Drugs for Pain Management Revenue, (US$, Mn), 2017-2028
Figure 37. GSK Drugs for Pain Management Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Pfizer Drugs for Pain Management Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Grunenthal Drugs for Pain Management Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Sanofi Drugs for Pain Management Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Bayer Drugs for Pain Management Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. AstraZeneca Drugs for Pain Management Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Eli Lilly Drugs for Pain Management Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Endo Drugs for Pain Management Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Merck Drugs for Pain Management Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Yunnan Baiyao Drugs for Pain Management Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Teikoku Seiyaku Drugs for Pain Management Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Teva Drugs for Pain Management Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. J&J Drugs for Pain Management Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Assertio Therapeutics Drugs for Pain Management Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Allergan Drugs for Pain Management Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
